Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1995 1
1998 1
2007 1
2008 2
2009 6
2010 5
2011 10
2012 10
2013 19
2014 14
2015 1
2016 12
2017 7
2018 17
2019 27
2020 15
2021 11
2022 5
2023 7
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

175 results

Results by year

Filters applied: . Clear all
Page 1
Vehicles Always Matter.
Kircik LH. Kircik LH. J Drugs Dermatol. 2019 Feb 1;18(2s):s99. J Drugs Dermatol. 2019. PMID: 30811152
Correction.
Hashim PW, Nia JK, Terrano D, Goldenberg G, Kircik LH. Hashim PW, et al. Among authors: kircik lh. J Drugs Dermatol. 2018 Feb 1;17(2):236. J Drugs Dermatol. 2018. PMID: 29462234
Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical Trials.
Lebwohl MG, Kircik LH, Moore AY, Stein Gold L, Draelos ZD, Gooderham MJ, Papp KA, Bagel J, Bhatia N, Del Rosso JQ, Ferris LK, Green LJ, Hebert AA, Jones T, Kempers SE, Pariser DM, Yamauchi PS, Zirwas M, Albrecht L, Devani AR, Lomaga M, Feng A, Snyder S, Burnett P, Higham RC, Berk DR. Lebwohl MG, et al. Among authors: kircik lh. JAMA. 2022 Sep 20;328(11):1073-1084. doi: 10.1001/jama.2022.15632. JAMA. 2022. PMID: 36125472 Free PMC article.
Management of Atopic Dermatitis.
Kircik LH. Kircik LH. J Drugs Dermatol. 2019 Feb 1;18(2s):s111. J Drugs Dermatol. 2019. PMID: 30811154
Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: A Randomized Phase II Study of the First Triple-Combination Drug.
Stein Gold L, Baldwin H, Kircik LH, Weiss JS, Pariser DM, Callender V, Lain E, Gold M, Beer K, Draelos Z, Sadick N, Pillai R, Bhatt V, Tanghetti EA. Stein Gold L, et al. Among authors: kircik lh. Am J Clin Dermatol. 2022 Jan;23(1):93-104. doi: 10.1007/s40257-021-00650-3. Epub 2021 Oct 21. Am J Clin Dermatol. 2022. PMID: 34674160 Free PMC article. Clinical Trial.
Efficacy of Roflumilast Foam, 0.3%, in Patients With Seborrheic Dermatitis: A Double-blind, Vehicle-Controlled Phase 2a Randomized Clinical Trial.
Zirwas MJ, Draelos ZD, DuBois J, Kircik LH, Moore AY, Stein Gold L, Alonso-Llamazares J, Bukhalo M, Bruce S, Eads K, Green LJ, Guenthner ST, Ferris LK, Forman SB, Kempers SE, Lain E, Lynde CW, Pariser DM, Toth DP, Yamauchi PS, Higham RC, Krupa D, Burnett P, Berk DR. Zirwas MJ, et al. Among authors: kircik lh. JAMA Dermatol. 2023 Jun 1;159(6):613-620. doi: 10.1001/jamadermatol.2023.0846. JAMA Dermatol. 2023. PMID: 37133856 Free PMC article. Clinical Trial.
Scalp psoriasis.
Kircik LH, Kumar S. Kircik LH, et al. J Drugs Dermatol. 2010 Aug;9(8 Suppl ODAC Conf Pt 2):s101-5. J Drugs Dermatol. 2010. PMID: 20715392 Review.
Treatment of Impetigo and Antimicrobial Resistance.
Schachner LA, Lynde CW, Kircik LH, Torrelo A, Hohl D, Kwong P, Oza V, Andriessen A, Hebert AA. Schachner LA, et al. Among authors: kircik lh. J Drugs Dermatol. 2021 Apr 1;20(4):366-372. doi: 10.36849/JDD.2021.5795. J Drugs Dermatol. 2021. PMID: 33852242 Review.
175 results